Stock Analysis on Net

UnitedHealth Group Inc. (NYSE:UNH)

$24.99

Analysis of Long-term (Investment) Activity Ratios
Quarterly Data

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Long-term Activity Ratios (Summary)

UnitedHealth Group Inc., long-term (investment) activity ratios (quarterly data)

Microsoft Excel
Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net fixed asset turnover
Total asset turnover
Equity turnover

Based on: 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


Net fixed asset turnover

The net fixed asset turnover ratio exhibits a generally upward trend over the analyzed periods. Starting at approximately 30.76 in early 2021, the ratio fluctuates slightly but maintains an increasing trajectory, reaching a peak near 38.9 by mid-2024. Although there is a minor decline observed towards the end of 2024, the ratio stabilizes around 37.7 to 38.2 in early and mid-2025. This indicates an improving efficiency in generating revenue from net fixed assets over time, with a notable acceleration in asset utilization efficiency beginning in early 2024.

Total asset turnover

The total asset turnover ratio remains relatively stable with modest fluctuations throughout the periods. Initially, the ratio is about 1.27 in March 2021 and slightly increases, peaking at 1.34 late in 2021 and again in late 2023. Midway through 2022, the ratio dips to around 1.29 but recovers by the end of 2023. The ratio continues to hover near the 1.3 to 1.35 range into 2025, signifying a consistent capacity to generate sales from the company's total assets with some short-term variability.

Equity turnover

The equity turnover ratio displays a steady upward movement across the time frame. Starting just below 4.0 in early 2021, the ratio increases to over 4.1 by the end of 2021 and fluctuates slightly around this level through 2022. The trend gains momentum in 2023 and 2024, with the ratio reaching above 4.3 during mid-2024 and continuing a mild rise into mid-2025, where it nears 4.41. This progression suggests growing effectiveness in generating revenues relative to shareholder equity, indicating improved use of equity capital over the periods analyzed.


Net Fixed Asset Turnover

UnitedHealth Group Inc., net fixed asset turnover calculation (quarterly data)

Microsoft Excel
Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Selected Financial Data (US$ in millions)
Revenues, customers
Property, equipment and capitalized software, net
Long-term Activity Ratio
Net fixed asset turnover1
Benchmarks
Net Fixed Asset Turnover, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC

Based on: 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).

1 Q2 2025 Calculation
Net fixed asset turnover = (Revenues, customersQ2 2025 + Revenues, customersQ1 2025 + Revenues, customersQ4 2024 + Revenues, customersQ3 2024) ÷ Property, equipment and capitalized software, net
= ( + + + ) ÷ =

2 Click competitor name to see calculations.


The quarterly financial data reveals a steady upward trend in revenues from customers over the observed periods. Starting at approximately 69.7 billion US dollars in the first quarter of 2021, revenues gradually increase, with occasional accelerated growth phases, reaching around 110.5 billion US dollars by the second quarter of 2025. This consistent growth indicates effective sales expansion and possibly enhanced market penetration or price adjustments over time.

The net value of property, equipment, and capitalized software also shows an increasing trend, moving from about 8.5 billion US dollars at the start of 2021 to approximately 10.9 billion US dollars by mid-2025. Despite some minor fluctuations—such as a slight dip observed around early 2024—overall investment in fixed assets appears to be growing, which might reflect ongoing capital expenditures and infrastructure development supporting business operations.

The net fixed asset turnover ratio, calculated as revenue divided by net fixed assets, exhibits an improvement from roughly 30.8 in early 2021 to a higher range around 37.7 to 38.2 by mid-2025. This upward trend indicates enhanced efficiency in utilizing fixed assets to generate revenues. The ratio consistently stays above 30, suggesting effective asset management, with significant gains in asset productivity particularly noticeable around 2024, potentially reflecting operational improvements or asset optimization strategies.

Revenues, customers
Demonstrates consistent growth with revenue increasing by nearly 58% over the period, indicating positive business momentum.
Property, equipment and capitalized software, net
Shows steady capital asset growth with minor fluctuations, possibly correlating with strategic capital expenditure and asset management decisions.
Net fixed asset turnover
Improves significantly, suggesting the company is generating more revenue per dollar of fixed assets, reflecting improving operational efficiency.

In summary, the company's financial trends over these quarters reveal growth in both revenues and capital assets, accompanied by improved asset utilization efficiency. These patterns highlight sustained business expansion supported by strategic investments and effective resource management.


Total Asset Turnover

UnitedHealth Group Inc., total asset turnover calculation (quarterly data)

Microsoft Excel
Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Selected Financial Data (US$ in millions)
Revenues, customers
Total assets
Long-term Activity Ratio
Total asset turnover1
Benchmarks
Total Asset Turnover, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC

Based on: 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).

1 Q2 2025 Calculation
Total asset turnover = (Revenues, customersQ2 2025 + Revenues, customersQ1 2025 + Revenues, customersQ4 2024 + Revenues, customersQ3 2024) ÷ Total assets
= ( + + + ) ÷ =

2 Click competitor name to see calculations.


The analysis of the financial data reveals several key trends over the reported periods.

Revenues, customers
The revenue figures exhibit a consistent upward trajectory throughout the periods. Starting at approximately $69.7 billion, revenues steadily increase each quarter, reaching over $110 billion by the most recent period. This indicates a robust growth in the company's sales or service delivery to customers, reflecting positive demand and possibly expansion of market share or pricing increases.
Total assets
Total assets display a general increasing trend, rising from around $205 billion to approximately $309 billion during the timeline. The asset base grows significantly, especially over the middle to later periods, suggesting ongoing investments or acquisitions that expand the asset holdings. There is some volatility observed, for instance, a slight decline between certain quarters, but the broader trend remains positive.
Total asset turnover
The asset turnover ratio starts relatively high at about 1.27 and increases slightly through the early intervals, peaking at 1.34 before experiencing a drop to around 1.18 at one point. Subsequently, it recovers to fluctuate near 1.3-1.35 in the later periods. This ratio indicates how efficiently the company is using its assets to generate revenue. The fluctuation suggests periods of both increased efficiency and some relative declines, but overall the ratio remains strong, demonstrating effective asset utilization on average.

In summary, the company demonstrates solid revenue growth accompanied by an expanding asset base. Despite some variability in asset turnover, the efficiency at which assets are employed to generate revenue remains largely stable and positive, reflecting effective operational management amid expansion.


Equity Turnover

UnitedHealth Group Inc., equity turnover calculation (quarterly data)

Microsoft Excel
Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Selected Financial Data (US$ in millions)
Revenues, customers
Shareholders’ equity attributable to UnitedHealth Group
Long-term Activity Ratio
Equity turnover1
Benchmarks
Equity Turnover, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC

Based on: 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).

1 Q2 2025 Calculation
Equity turnover = (Revenues, customersQ2 2025 + Revenues, customersQ1 2025 + Revenues, customersQ4 2024 + Revenues, customersQ3 2024) ÷ Shareholders’ equity attributable to UnitedHealth Group
= ( + + + ) ÷ =

2 Click competitor name to see calculations.


The financial data over the observed periods highlights several key trends regarding the company’s revenues, shareholders’ equity, and equity turnover ratio.

Revenues
Revenues show a consistent upward trend from March 2021 through June 2025. Starting at approximately $69.7 billion in March 2021, revenues gradually increase each quarter with some fluctuations in the short term but maintain an overall growth trajectory.
There is noticeable acceleration in revenue growth beginning around early 2023, with quarterly revenues reaching approximately $91.1 billion in March 2023 and continuing to increase to roughly $110.5 billion by June 2025. This suggests an expanding customer base or enhanced pricing and service capabilities driving higher income.
Shareholders’ Equity Attributable to UnitedHealth Group
Shareholders’ equity also experiences a steady increase from about $66.4 billion in March 2021 to a peak near $94.5 billion in September 2024.
Following this peak, equity slightly declines to about $94.7 billion in June 2025, suggesting minor adjustments or distributions affecting the equity base. Overall, the equity growth aligns with revenue growth, reflecting retained earnings and possible capital inflows supporting the company’s expansion.
Equity Turnover Ratio
The equity turnover ratio, indicating the efficiency of utilizing shareholders’ equity to generate revenues, remains relatively stable across all quarters with minor fluctuations between 3.92 and 4.41.
The ratio experiences mild increases around mid-2022 and continues a gradual uptrend through mid-2025, peaking at 4.41. This improvement suggests the company is slightly enhancing its efficiency in generating revenues from its equity base over time.
Overall Insights
The combined trends indicate robust and sustained revenue growth supported by increasing shareholders’ equity. The consistent equity turnover ratio, with a tendency to improve, demonstrates that growth in revenues is being achieved efficiently relative to the equity employed.
This pattern points to effective management of capital resources and operational expansion, contributing to steady financial strengthening over the reported periods.